AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dayclazide-M 40 Tablet

Prescription Icon
Prescription Required

Marketer

Daylon Healthcare

Salt Composition

Gliclazide (40mg) + Metformin (500mg)

Overview Dayclazide-M 40 Tablet

GlucoDuo 40mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer GlucoDuo 40mg with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue this medication even with controlled blood sugar; discontinuation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a fast-acting glucose source (e.g., sugary snacks or juice) and maintain regular mealtimes to mitigate hypoglycemia. Alcohol increases hypoglycemia risk and should be avoided. Less frequent side effects may include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a possibility. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Inform your doctor of any history of heart disease before starting this medication; it may not be appropriate. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be necessary.

Primary Ingredients of Dayclazide-M 40 Tablet

No information provided. Please provide the text you wish to be rewritten.

Uses of Dayclazide-M 40 Tablet

Adult-onset diabetes

Major Benefits of Dayclazide-M 40 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dayclazide-M 40mg tablets should be administered with a meal.

Common Side effects of Dayclazide-M 40 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Dayclazide-M 40 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the Dayclazide-M 40 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Dayclazide-M 40 Tablet works:

Dayclazide-M 40 tablets contain gliclazide and metformin, two medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Dayclazide-M 40 Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Dayclazide-M 40 Tablet during pregnancy poses a confirmed risk to the fetus. Prescribing may occur exceptionally in life-threatening circumstances where potential benefits outweigh known hazards, as determined by a physician. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Dayclazide-M 40 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Dayclazide-M 40 Tablet cautiously, potentially requiring dosage modification under medical supervision. Dayclazide-M 40 Tablet is contraindicated in those with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Dayclazide-M 40 mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced starting dose is typically advised for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Dayclazide-M 40 Tablet :

Should you forget a Dayclazide-M 40 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Dayclazide-M 40 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dayclazide-M 40 Tablet

Dayclazide-M 40 Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Dayclazide-M 40 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Dayclazide-M 40 Tablet can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Dayclazide-M 40 Tablet can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Dayclazide-M 40 Tablet and seek immediate medical attention.
Prolonged Dayclazide-M 40 Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Dayclazide-M 40 Tablet is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Dayclazide-M 40 Tablet and alcohol is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Dayclazide-M 40 Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Dayclazide-M 40 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Dayclazide-M 40 Tablet can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Dayclazide-M 40 Tablet can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Dayclazide-M 40 Tablet and seek immediate medical attention.
Prolonged Dayclazide-M 40 Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Dayclazide-M 40 Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Dayclazide-M 40 Tablet is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Dayclazide-M 40 Tablet
48
MRP 55
12% off